Startups

Unfazed by critics over the legitimacy of its business model, Chinese healthcare crowdfunding site Shuidi raises $145 million from a star-studded list of investors.

Five-year-old startup raises $70 million in its third funding round in six months and claims to be the first to close series C funding among international shipping service providers in China.

China’s electric vehicle market is getting increasingly sophisticated as the number of EV-focused service providers grow. DSTcar is one of them.

Sino-US trade tensions have not discouraged Korean investors from China's booming biotech industry as the cancer immunology specialist completes its Series B funding.

The Shanghai-based biopharmaceutical startup is the latest to raise capital from private investors as oncology becomes one of the hottest fields in biopharma development.

Chinese precision medicine developer 3D Medicines wants to complete its Series A funding before it looks at an IPO in Hong Kong next year.

Demographics and GDP growth mean that consumer tech and fintech still have the potential to grow in the region, and that is why Vertex is raising more money in the next few months.

Amid a booming regional startup scene, venture debt could help complement growth-stage financing, the Sassoon family office-backed company hopes.

Instead of hoping for the usual exit route of an IPO, backers of Singapore Life are aiming for a reasonable buyout in the future.